ロード中...
Fluorescence-guided Resection of Experimental Malignant Glioma Using Cetuximab-IRDye 800CW
The standard treatment for Glioblastoma Multiforme (GBM) remains maximal safe surgical resection. Here, we evaluated the ability of a systemically administered antibody-dye probe conjugate (cetuximab-IRDye 800CW) to provide sufficient fluorescent contrast for surgical resection of disease in both su...
保存先:
| 出版年: | Br J Neurosurg |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4740249/ https://ncbi.nlm.nih.gov/pubmed/26073144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02688697.2015.1056090 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|